VVOS News and Press, Vivos Therapeutics Inc. From 11/30/23

2023-11-30 10:00:02 ET More on Health Care Select Sector SPDR Ideal Pairs Trade Into 2024: Health Vs. Hype: Capitalizing On A Therapeutic Turn And A Tech Tumble For further details see: Redhill Biopharma, Ampio Pharmaceuticals among healthcare movers

2023-11-30 08:40:55 ET Losers: Vivos Therapeutics ( VVOS ) -34% . Redhill Biopharma Ltd. ( RDHL ) -26% . Yoshiharu Global Co ( YOSH ) -25% . XORTX Therapeutics XRTX -18% announces $3.70M US ATM offering . Pure Storage PSTG -15% after...

--News Direct-- Vivos Therapeutics CEO Kirk Huntsman joined Steve Darling from Proactive to announce a significant milestone for the company with its first-ever 510(k) clearance from the US Food and Drug Administration (FDA). The clearance is for the treatment of severe obstructive sleep ...

2023-11-29 12:24:37 ET DENVER, Colo., Nov. 29, 2023 ( www.247marketnews.com )- The following companies published announcements or are trading higher on higher-than-usual midday volume; Vivos Therapeutics Inc (NASDAQ: VVOS), Redhill Biopharma Ltd (NASDAQ: RDHL), GameStop Corp (NYSE: GME)...

Vivos Therapeutics, Inc. (NASDAQ: VVOS) is one of today's top gainers. The company's shares have moved 324.17% on the day to $ 18.62 . Vivos Therapeutics, Inc., a medical technology company, develops and commercializes treatment alternatives for patients with dentofacial abnormalities, o...

2023-11-29 10:02:31 ET DENVER, Colo., Nov. 29, 2023 ( www.247marketnews.com )- The following companies published announcements or are trading higher on higher-than-usual volume; Vivos Therapeutics Inc (NASDAQ: VVOS), Rover Group Inc (NASDAQ: ROVR), Redhill Biopharma Ltd (NASDAQ: RDHL), ...

2023-11-29 08:11:13 ET DENVER, Colo., Nov 29, 2023 ( www.247marketnews.com )- Vivos Therapeutics Inc (NASDAQ: VVOS) announced, this morning, that the U.S. Food and Drug Administration (FDA) granted 510(k) clearance for treating severe obstructive sleep apnea (OSA) in adults using the Vi...

2023-11-29 08:07:37 ET Vivos Therapeutics ( NASDAQ: VVOS ) shares rallied premarket on Wednesday after the medtech firm gained first ever FDA 510(k) clearance for oral device treatment of severe obstructive sleep apnea (OSA). The clearance is backed by statistically signific...

LITTLETON, Colo., Nov. 29, 2023 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (the “Company” or “Vivos”) (NASDAQ:VVOS) , a leading medical device and technology company specializing in the development and commercialization of highly effective proprietary treatments ...

2023-11-23 06:45:55 ET More on Vivos Therapeutics Vivos Therapeutics, Inc. (VVOS) Q3 2023 Earnings Call Transcript Vivos Therapeutics prices $4M public offering Vivos Therapeutics announces 1-for-25 reverse stock split Seeking Alpha’s Quant Rating on V...